Product Details for ANDA 078690
CARBIDOPA AND LEVODOPA (CARBIDOPA; LEVODOPA)
10MG;100MG
Marketing Status: Prescription
25MG;100MG
Marketing Status: Prescription
25MG;250MG
Marketing Status: Prescription
10MG;100MG
Marketing Status: Prescription
Active Ingredient: CARBIDOPA; LEVODOPA
Proprietary Name: CARBIDOPA AND LEVODOPA
Dosage Form; Route of Administration: TABLET, ORALLY DISINTEGRATING; ORAL
Strength: 10MG;100MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A078690
Product Number: 001
Approval Date: Jul 31, 2009
Applicant Holder Full Name: SUN PHARMACEUTICAL INDUSTRIES LTD
Marketing Status: Prescription
Patent and Exclusivity Information
CARBIDOPA AND LEVODOPA (CARBIDOPA; LEVODOPA)
Proprietary Name: CARBIDOPA AND LEVODOPA
Dosage Form; Route of Administration: TABLET, ORALLY DISINTEGRATING; ORAL
Strength: 10MG;100MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A078690
Product Number: 001
Approval Date: Jul 31, 2009
Applicant Holder Full Name: SUN PHARMACEUTICAL INDUSTRIES LTD
Marketing Status: Prescription
Patent and Exclusivity Information
25MG;100MG
Marketing Status: Prescription
Active Ingredient: CARBIDOPA; LEVODOPA
Proprietary Name: CARBIDOPA AND LEVODOPA
Dosage Form; Route of Administration: TABLET, ORALLY DISINTEGRATING; ORAL
Strength: 25MG;100MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A078690
Product Number: 002
Approval Date: Jul 31, 2009
Applicant Holder Full Name: SUN PHARMACEUTICAL INDUSTRIES LTD
Marketing Status: Prescription
Patent and Exclusivity Information
CARBIDOPA AND LEVODOPA (CARBIDOPA; LEVODOPA)
Proprietary Name: CARBIDOPA AND LEVODOPA
Dosage Form; Route of Administration: TABLET, ORALLY DISINTEGRATING; ORAL
Strength: 25MG;100MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A078690
Product Number: 002
Approval Date: Jul 31, 2009
Applicant Holder Full Name: SUN PHARMACEUTICAL INDUSTRIES LTD
Marketing Status: Prescription
Patent and Exclusivity Information
25MG;250MG
Marketing Status: Prescription
Active Ingredient: CARBIDOPA; LEVODOPA
Proprietary Name: CARBIDOPA AND LEVODOPA
Dosage Form; Route of Administration: TABLET, ORALLY DISINTEGRATING; ORAL
Strength: 25MG;250MG
Reference Listed Drug: No
Reference Standard: Yes
TE Code:
Application Number: A078690
Product Number: 003
Approval Date: Jul 31, 2009
Applicant Holder Full Name: SUN PHARMACEUTICAL INDUSTRIES LTD
Marketing Status: Prescription
Patent and Exclusivity Information
Proprietary Name: CARBIDOPA AND LEVODOPA
Dosage Form; Route of Administration: TABLET, ORALLY DISINTEGRATING; ORAL
Strength: 25MG;250MG
Reference Listed Drug: No
Reference Standard: Yes
TE Code:
Application Number: A078690
Product Number: 003
Approval Date: Jul 31, 2009
Applicant Holder Full Name: SUN PHARMACEUTICAL INDUSTRIES LTD
Marketing Status: Prescription
Patent and Exclusivity Information